NCT02169934View on ClinicalTrials.gov

A Study to Investigate the Metabolism and Excretion of [14C]-TRV130 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

May 31, 2015

Conditions
Healthy
Interventions
DRUG

Radiolabeled TRV130

A single 2 mg IV dose administered as a 10 mL manual IV push over 2 minutes

Trial Locations (1)

53704

Madison Clinical Research Unit, Madison

All Listed Sponsors
lead

Trevena Inc.

INDUSTRY

NCT02169934 - A Study to Investigate the Metabolism and Excretion of [14C]-TRV130 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter